亚太合同研究组织 (CRO) 市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析(早期开发服务、临床研究服务、实验室服务和批准后服务);最终用户(制药和生物技术公司以及医疗器械公司)和地理位置

Historic Data: 2018-2019   |   Base Year: 2020   |   Forecast Period: 2021-2028


No. of Pages: 95    |    Report Code: TIPRE00008345    |    Category: Life Sciences

Asia Pacific Contract Research Organization (CRO) Market

2020年亚太合同研究组织市场价值为81.120亿美元,预计到2028年将达到183.9987亿美元;预计 2021 年至 2028 年复合年增长率为 11.2%。

 

合同研究组织 (CRO) 提供支持服务制药、生物技术和医疗器械公司的整个产品开发过程。医药&生物技术公司和医疗器械行业需要各种测试服务,如临床前服务、临床研究服务、分析测试服务、生物分析测试服务和监管服务。 CRO 专门用于执行这些测试服务,以减少公司的内部成本和时间,需要执行广泛的测试服务以符合国家和国际监管标准

 

亚洲大陆似乎是一个快速增长的进行具有成本效益的临床试验的目的地。此外,监管合规的便利性和顶级临床机构的存在进一步有助于亚太地区成为临床试验进行目的地的新选择。外包是生物制药行业不可或缺的一部分,主要发生在研发 (R&D) 的临床阶段。该地区临床试验数量的增加也归因于未接受治疗的患者库的存在和容易获取。

 

肝炎等疾病的高发病率、中风和肺癌使亚太地区成为进行临床试验的有希望的目的地。根据世界卫生组织(WHO)数据库研究,2009年至2018年间亚太地区注册临床试验总数超过125,000项。这意味着亚洲地区的临床试验总数增加了7倍。报告还表明,日本进行的临床试验数量最多,约占该地区试验总数的 30.8%。亚太地区临床试验数量的年均增幅大于美国、加拿大和欧盟国家。根据 PubMed 2019 年 9 月发布的报告,伊朗的临床试验数量增幅为亚洲最高,2019 年较 2018 年增长 41%。因此,该地区临床试验数量的增加意味着该地区临床试验数量的增加对外包研发活动的需求,从而推动了亚太地区合同研究组织 (CRO) 市场在预测年内的增长。

 

市场见解

研究与开发 (R&D) 是公司业务的重要组成部分。制药和生物技术公司专注于研发(R&D),为各种治疗应用提供具有最大医疗和商业潜力的新分子。这些公司主要投资于研发,旨在向市场提供高质量和创新的产品。生物制药公司的研发支出多年来也有所增加。此外,亚洲生物制药行业的快速发展为投资者创造了一个拥有充足资金的群体。根据《2018年亚洲十大生物制药集群》发布的报告,亚洲投资者为生物制药初创企业投资了约42亿美元,因为它们在未来几年具有巨大的扩张潜力

 

类型:洞察

亚太合同研究组织市场根据类型分为早期开发服务、临床研究服务、实验室服务、以及审批后服务。 2020年,临床研究服务领域占据了更大的市场份额。然而,预计该领域在预测期内的市场复合年增长率将更高。

 

亚太合同研究组织市场(按类型) 2020 年和 2028 年


 

最终用户:

<根据最终用户,亚太合同研究组织市场分为制药和生物技术公司以及医疗器械公司。制药和生物技术公司细分市场在 2020 年占据最大市场份额,预计该细分市场在 2021-2028 年复合年增长率最高。

 

战略见解

亚太合同研究组织市场的参与者采用协作和伙伴关系策略,通过引入技术先进的产品来满足最终用户的需求,这些策略极大地支持了市场的增长。


按类型

  • 早期开发服务
    • 药物发现服务< /li>
    • 临床前服务
  • 临床研究服务
  • 实验室服务
  • 批准后服务
  • li>

按最终用户

  • 制药和生物技术公司
  • 医疗器械公司

按国家/地区

  • 中国
  • 印度
  • 韩国
  • 日本< /li>
  • 澳大利亚


公司简介

  • IQVIA Inc.
  • Parexel International Corporation
  • Charles River Laboratories, Inc.
  • ACM Global Laboratories
  • Merck KGaA(Bio Reliance Corporation)
  • Celerion< /li>
  • Clinitude
  • 美国实验室控股公司(科文斯公司)
  • Novotech
  • Icon PLC


Asia Pacific Contract Research Organization (CRO) Strategic Insights

Strategic insights for Asia Pacific Contract Research Organization (CRO) involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-contract-research-organization-cro-market-strategic-framework.webp
Get more information on this report

Asia Pacific Contract Research Organization (CRO) Report Scope

Report Attribute Details
Market size in 2020 US$ 8,112.00 Million
Market Size by 2028 US$ 18,399.87 Million
Global CAGR (2021 - 2028) 11.2%
Historical Data 2018-2019
Forecast period 2021-2028
Segments Covered By 类型
  • 早期开发服务
  • 临床研究服务
  • 实验室服务
  • 上市后服务
By 最终用户
  • 制药和生物技术公司以及医疗器械公司
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • IQVIA Inc.
  • Parexel International Corporation
  • Charles River Laboratories, Inc.
  • ACM Global Laboratories
  • Merck KGaA (Bio Reliance Corporation)
  • Celerion
  • Clinitude
  • Laboratory Corporation of America Holdings (Covance Inc.)
  • Novotech
  • Icon PLC
  • Get more information on this report

    Asia Pacific Contract Research Organization (CRO) Regional Insights

    The regional scope of Asia Pacific Contract Research Organization (CRO) refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-contract-research-organization-cro-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Contract Research Organization (CRO) Market

    The List of Companies - Asia Pacific Contract Research Organization (CRO) Market

    1. IQVIA Inc.
    2. Parexel International Corporation
    3. Charles River Laboratories, Inc.
    4. ACM Global Laboratories
    5. Merck KGaA (Bio Reliance Corporation)
    6. Celerion
    7. Clinitude
    8. Laboratory Corporation of America Holdings (Covance Inc.)
    9. Novotech
    10. Icon PLC
    Frequently Asked Questions
    How big is the Asia Pacific Contract Research Organization (CRO) Market?

    The Asia Pacific Contract Research Organization (CRO) Market is valued at US$ 8,112.00 Million in 2020, it is projected to reach US$ 18,399.87 Million by 2028.

    What is the CAGR for Asia Pacific Contract Research Organization (CRO) Market by (2021 - 2028)?

    As per our report Asia Pacific Contract Research Organization (CRO) Market, the market size is valued at US$ 8,112.00 Million in 2020, projecting it to reach US$ 18,399.87 Million by 2028. This translates to a CAGR of approximately 11.2% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Contract Research Organization (CRO) Market report typically cover these key segments-

  • 类型 (早期开发服务, 临床研究服务, 实验室服务, 上市后服务)
  • 最终用户 (制药和生物技术公司以及医疗器械公司)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Contract Research Organization (CRO) Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Contract Research Organization (CRO) Market report:

  • Historic Period : 2018-2019
  • Base Year : 2020
  • Forecast Period : 2021-2028
  • Who are the major players in Asia Pacific Contract Research Organization (CRO) Market?

    The Asia Pacific Contract Research Organization (CRO) Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • IQVIA Inc.
  • Parexel International Corporation
  • Charles River Laboratories, Inc.
  • ACM Global Laboratories
  • Merck KGaA (Bio Reliance Corporation)
  • Celerion
  • Clinitude
  • Laboratory Corporation of America Holdings (Covance Inc.)
  • Novotech
  • Icon PLC
  • Who should buy this report?

    The Asia Pacific Contract Research Organization (CRO) Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Contract Research Organization (CRO) Market value chain can benefit from the information contained in a comprehensive market report.